Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
QNCX | Quince Therapeutics, Inc. | CEO AND CHIEF MEDICAL OFFICER, Director | $648 K | +$210 K | +48% | Feb 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|